Construcciones y Auxiliar de Ferrocarriles SA:戦略・SWOT・企業財務分析

◆英語タイトル:Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015709
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Construcciones y Auxiliar de Ferrocarriles SA – Strategy, SWOT and Corporate Finance Report
Summary

Construcciones y Auxiliar de Ferrocarriles SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Construcciones y Auxiliar de Ferrocarriles, S.A. (CAF) manufactures and supplies railway vehicles across the world. CAF’s product portfolio primarily includes rolling stock and rail components. The major products offered by the company include high speed trains, commuter, metro, trams, light rail vehicles, and locomotives. The company’s rail components or rolling gear equipment includes wheels, axels, wheel sets and gear units. The company also offers a wide range of rail services such as maintenance, refurbishment and upgrading, and project management, auxiliary vehicle service and after sales services. The company’s manufacturing units are located in Spain, France, the US, Mexico and Brazil. CAF is headquartered in Beasain, Guipuzcoa, Spain.

Scope

- Detailed information on Construcciones y Auxiliar de Ferrocarriles SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Construcciones y Auxiliar de Ferrocarriles SA in the form of a SWOT analysis
- An in-depth view of the business model of Construcciones y Auxiliar de Ferrocarriles SA including a breakdown and examination of key business segments
- Intelligence on Construcciones y Auxiliar de Ferrocarriles SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Construcciones y Auxiliar de Ferrocarriles SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Construcciones y Auxiliar de Ferrocarriles SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Construcciones y Auxiliar de Ferrocarriles SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Construcciones y Auxiliar de Ferrocarriles SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Construcciones y Auxiliar de Ferrocarriles SA: Company Overview
Construcciones y Auxiliar de Ferrocarriles SA: Overview and Key Facts
Construcciones y Auxiliar de Ferrocarriles SA: Overview
Construcciones y Auxiliar de Ferrocarriles SA: Key Facts
Construcciones y Auxiliar de Ferrocarriles SA: Key Employees
Construcciones y Auxiliar de Ferrocarriles SA: Major Products and Services
Construcciones y Auxiliar de Ferrocarriles SA: Company History
Construcciones y Auxiliar de Ferrocarriles SA: Management Statement
Construcciones y Auxiliar de Ferrocarriles SA: Locations and Subsidiaries
Construcciones y Auxiliar de Ferrocarriles SA: Key Competitors
Construcciones y Auxiliar de Ferrocarriles SA: Company Analysis
Construcciones y Auxiliar de Ferrocarriles SA: Business Description
Construcciones y Auxiliar de Ferrocarriles SA: SWOT Analysis
Construcciones y Auxiliar de Ferrocarriles SA: SWOT Overview
Construcciones y Auxiliar de Ferrocarriles SA: Strengths
Construcciones y Auxiliar de Ferrocarriles SA: Weaknesses
Construcciones y Auxiliar de Ferrocarriles SA: Opportunities
Construcciones y Auxiliar de Ferrocarriles SA: Threats
Construcciones y Auxiliar de Ferrocarriles SA: Recent Developments
Construcciones y Auxiliar de Ferrocarriles SA: News and Events Summary
Construcciones y Auxiliar de Ferrocarriles SA: Business Expansion
Construcciones y Auxiliar de Ferrocarriles SA: Contracts
Construcciones y Auxiliar de Ferrocarriles SA: Financial Performance
Construcciones y Auxiliar de Ferrocarriles SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Construcciones y Auxiliar de Ferrocarriles SA: Key Facts
Table 2: Construcciones y Auxiliar de Ferrocarriles SA: Key Employees
Table 3: Construcciones y Auxiliar de Ferrocarriles SA: Locations and Subsidiaries
Table 4: Construcciones y Auxiliar de Ferrocarriles SA: Key Competitors
Table 5: Construcciones y Auxiliar de Ferrocarriles SA: News and Events Summary
Table 6: Construcciones y Auxiliar de Ferrocarriles SA: Business Expansion
Table 7: Construcciones y Auxiliar de Ferrocarriles SA: Contracts
Table 8: Construcciones y Auxiliar de Ferrocarriles SA: Financial Performance
Table 9: Construcciones y Auxiliar de Ferrocarriles SA: Strategy and Operations

★海外企業調査レポート[Construcciones y Auxiliar de Ferrocarriles SA:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報
    Summary GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epider …
  • ROHA Dyechem Pvt. Ltd.:企業の戦略・SWOT・財務情報
    ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ultra Petroleum Corp. (UPL)-石油・ガス分野:企業M&A・提携分析
    Summary Ultra Petroleum Corp. (Ultra) is an independent upstream company which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops its long-life natural gas reserves in the Green River Basin of Wyoming, the Pinedale and Jonah fields, and Appalachian Basin …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HealthTronics Inc:医療機器:M&Aディール及び事業提携情報
    Summary HealthTronics Inc (HealthTronics), a subsidiary of Altaris Capital Partners, LLC, carries out manufacturing, marketing and distribution of lithotripters, cryoblation devices and nerve monitoring equipment. The various products and services offered by the company include lithotripsy services, …
  • Tokyo Tatemono Co., Ltd:戦略・SWOT・企業財務分析
    Tokyo Tatemono Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Tokyo Tatemono Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Renova Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Renova Therapeutics Inc (Renova) is a drug development company that focuses on the development of peptide infusion therapies and gene therapy treatments for cardiovascular and metabolic diseases. The company’s pipeline products include RT-100, RT-200, RT-110, RT-400, RT-210 and RT-300. Its R …
  • Huesker Synthetic GmbH:企業の戦略・SWOT・財務情報
    Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務分析
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Caldic B.V.:企業の戦略・SWOT・財務情報
    Caldic B.V. - Strategy, SWOT and Corporate Finance Report Summary Caldic B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Eloxx Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆